If you made any changes in Pure these will be visible here soon.

Research Output 1987 2019

Filter
Article
2019
Open Access
temozolomide
Chemotherapy
chemotherapy
Glioblastoma
Nucleotides

Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype–phenotype study in neurofibromatosis type 1

Koczkowska, M., Callens, T., Chen, Y., Gomes, A., Hicks, A. D., Sharp, A., Johns, E., Uhas, K. A., Armstrong, L., Bosanko, K. A., Babovic-Vuksanovic, D., Baker, L., Basel, D. G., Bengala, M., Bennett, J. T., Chambers, C., Clarkson, L. K., Clementi, M., Cortés, F. M., Cunningham, M. & 88 others, D'Agostino, M. D., Delatycki, M. B., Digilio, M. C., Dosa, L., Esposito, S., Fox, S., Freckmann, M. L., Fauth, C., Giugliano, T., Giustini, S., Goetsch, A., Goldberg, Y., Greenwood, R. S., Griffis, C., Gripp, K. W., Gupta, P., Haan, E., Hachen, R. K., Haygarth, T. L., Hernández-Chico, C., Hodge, K., Hopkin, R. J., Hudgins, L., Janssens, S., Keller, K., Kelly-Mancuso, G., Kochhar, A., Korf, B. R., Lewis, A. M., Liebelt, J., Lichty, A., Listernick, R. H., Lyons, M. J., Maystadt, I., Martinez Ojeda, M., McDougall, C., McGregor, L. K., Melis, D., Mendelsohn, N., Nowaczyk, M. J. M., Ortenberg, J., Panzer, K., Pappas, J. G., Pierpont, M. E., Piluso, G., Pivnick, E. K., Pinna, V., Pond, D. A., Powell, C. M., Rogers, C., Ruhrman Shahar, N., Rutledge, S. L., Saletti, V., Sandaradura, S. A., Santoro, C., Schatz, U. A., Schreiber, A., Scott, D. A., Sellars, E. A., Sheffer, R., Siqveland, E., Slopis, J. M., Smith, R., Spalice, A., Stockton, D. W., Streff, H., Theos, A., Tomlinson, G. E., Tran, G., Trapane, P. L., Trevisson, E., Ullrich, N. J., Van den Ende, J., Schrier Vergano, S. A., Wallace, S. E., Wangler, M. F., Weaver, D. D., Yohay, K. H., Zackai, E., Zonana, J., Zurcher, V., Claes, K. B. M., Eoli, M., Martin, Y., Wimmer, K., De Luca, A., Legius, E. & Messiaen, L. M., Jan 1 2019, (Accepted/In press) In : Human Mutation.

Research output: Contribution to journalArticle

Open Access
Neurofibroma
Neurofibromatosis 1
Plexiform Neurofibroma
Optic Nerve Glioma
Cardiovascular Abnormalities

Management of epilepsy in brain tumors

Brain Tumor-related Epilepsy study group of Italian League Against Epilepsy (LICE), Aug 7 2019, In : Neurological Sciences.

Research output: Contribution to journalArticle

Brain Neoplasms
Anticonvulsants
Epilepsy
etiracetam
Patient Advocacy

Management of epilepsy in brain tumors

Maschio, M., Aguglia, U., Avanzini, G., Banfi, P., Buttinelli, C., Capovilla, G., Casazza, M. M. L., Colicchio, G., Coppola, A., Costa, C., Dainese, F., Daniele, O., De Simone, R., Eoli, M., Gasparini, S., Giallonardo, A. T., La Neve, A., Maialetti, A., Mecarelli, O., Melis, M. & 17 others, Michelucci, R., Paladin, F., Pauletto, G., Piccioli, M., Quadri, S., Ranzato, F., Rossi, R., Salmaggi, A., Terenzi, R., Tisei, P., Villani, F., Vitali, P., Vivalda, L. C., Zaccara, G., Zarabla, A., Beghi, E. & (LICE), O. B. O. B. T. E. S. G. O. I. L. A. E., 2019, In : Neurological Sciences. 40, 10, p. 2217-2234 18 p.

Research output: Contribution to journalArticle

Management of epilepsy in brain tumors

(LICE), B. T. E. S. G. O. I. L. A. E., Maschio, M., Aguglia, U., Avanzini, G., Banfi, P., Buttinelli, C., Capovilla, G., Casazza, M. M. L., Colicchio, G., Coppola, A., Costa, C., Dainese, F., Daniele, O., De Simone, R., Eoli, M., Gasparini, S., Giallonardo, A. T., La Neve, A., Maialetti, A., Mecarelli, O. & 17 others, Melis, M., Michelucci, R., Paladin, F., Pauletto, G., Piccioli, M., Quadri, S., Ranzato, F., Rossi, R., Salmaggi, A., Terenzi, R., Tisei, P., Villani, F., Vitali, P., Vivalda, L. C., Zaccara, G., Zarabla, A. & Beghi, E., Aug 7 2019, In : Neurol. Sci.. 40, p. 2217-2234

Research output: Contribution to journalArticle

Open Access
Optic Nerve Glioma
Untranslated RNA
Neurofibromatosis 1
Phenotype
Long Noncoding RNA

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

Lombardi, G., De Salvo, G. L., Brandes, A. A., Eoli, M., Rudà, R., Faedi, M., Lolli, I., Pace, A., Daniele, B., Pasqualetti, F., Rizzato, S., Bellu, L., Pambuku, A., Farina, M., Magni, G., Indraccolo, S., Gardiman, M. P., Soffietti, R. & Zagonel, V., Jan 2019, In : The Lancet. Oncology. 20, 1, p. 110-119 10 p.

Research output: Contribution to journalArticle

Lomustine
Glioblastoma
Survival
temozolomide
Italy

Risk of optic pathway glioma in neurofibromatosis type 1: No evidence of genotype–phenotype correlations in a large independent cohort

Melloni, G., Eoli, M., Cesaretti, C., Bianchessi, D., Ibba, M. C., Esposito, S., Scuvera, G., Morcaldi, G., Micheli, R., Piozzi, E., Avignone, S., Chiapparini, L., Pantaleoni, C., Natacci, F., Finocchiaro, G. & Saletti, V., Dec 2019, In : Cancers. 11, 12, 1838.

Research output: Contribution to journalArticle

Open Access
Optic Nerve Glioma
Neurofibromatosis 1
Mutation
Serine
Cysteine

Stroke-like events after brain radiotherapy: a large series with long-term follow-up

Di Stefano, A. L., Berzero, G., Ducray, F., Eoli, M., Pichiecchio, A., Farina, L. M., Cuccarini, V., Brunelli, M. C., Diamanti, L., Condette Auliac, S., Salmaggi, A., Silvani, A., Giometto, B., Pace, A., Vidiri, A., Bourdain, F., Bastianello, S., Ceroni, M. & Marchioni, E., Apr 2019, In : European Journal of Neurology. 26, 4, p. 639-650 12 p.

Research output: Contribution to journalArticle

Radiotherapy
Stroke
Brain
Radiation Injuries
Radiation Effects
2018

Fluorescein-guided surgery for resection of high-grade gliomas: A multicentric prospective phase II study (FLUOGLIO)

Acerbi, F., Broggi, M., Schebesch, K. M., Höhne, J., Cavallo, C., De Laurentis, C., Eoli, M., Anghileri, E., Servida, M., Boffano, C., Pollo, B., Schiariti, M., Visintini, S., Montomoli, C., Bosio, L., Corte, E. L., Broggi, G., Brawanski, A. & Ferroli, P., Jan 1 2018, In : Clinical Cancer Research. 24, 1, p. 52-61 10 p.

Research output: Contribution to journalArticle

Fluorescein
Glioma
Neoplasms
Sensitivity and Specificity
Survival

Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844–848

Koczkowska, M., Chen, Y., Callens, T., Gomes, A., Sharp, A., Johnson, S., Hsiao, M. C., Chen, Z., Balasubramanian, M., Barnett, C. P., Becker, T. A., Ben-Shachar, S., Bertola, D. R., Blakeley, J. O., Burkitt-Wright, E. M. M., Callaway, A., Crenshaw, M., Cunha, K. S., Cunningham, M., D'Agostino, M. D. & 55 others, Dahan, K., De Luca, A., Destrée, A., Dhamija, R., Eoli, M., Evans, D. G. R., Galvin-Parton, P., George-Abraham, J. K., Gripp, K. W., Guevara-Campos, J., Hanchard, N. A., Hernández-Chico, C., Immken, L. D., Janssens, S., Jones, K. J., Keena, B. A., Kochhar, A., Liebelt, J., Martir-Negron, A., Mahoney, M. J., Maystadt, I., McDougall, C., McEntagart, M., Mendelsohn, N., Miller, D. T., Mortier, G., Morton, J., Pappas, J., Plotkin, S. R., Pond, D., Rosenbaum, K., Rubin, K., Russell, L., Rutledge, L. S., Saletti, V., Schonberg, R., Schreiber, A., Seidel, M., Siqveland, E., Stockton, D. W., Trevisson, E., Ullrich, N. J., Upadhyaya, M., van Minkelen, R., Verhelst, H., Wallace, M. R., Yap, Y. S., Zackai, E., Zonana, J., Zurcher, V., Claes, K., Martin, Y., Korf, B. R., Legius, E. & Messiaen, L. M., Jan 4 2018, In : American Journal of Human Genetics. 102, 1, p. 69-87 19 p.

Research output: Contribution to journalArticle

Neurofibromatosis 1
Genetic Association Studies
Missense Mutation
Codon
Phenotype
temozolomide
Glioblastoma
Immunotherapy
Dendritic Cells
T-Lymphocytes

The molecular landscape of glioma in patients with Neurofibromatosis 1

D'Angelo, F., Ceccarelli, M., Tala, J., Garofano, L., Zhang, J., Frattini, V., Caruso, F. P., Lewis, G., Alfaro, K. D., Bauchet, L., Berzero, G., Cachia, D., Cangiano, M., Capelle, L., de Groot, J., DiMeco, F., Ducray, F., Farah, W., Finocchiaro, G., Goutagny, S. & 27 others, Kamiya-Matsuoka, C., Lavarino, C., Loiseau, H., Lorgis, V., Marras, C. E., McCutcheon, I., Nam, D-H., Ronchi, S., Saletti, V., Seizeur, R., Slopis, J., Suñol, M., Vandenbos, F., Varlet, P., Vidaud, D., Watts, C., Tabar, V., Reuss, D. E., Kim, S-K., Meyronet, D., Mokhtari, K., Salvador, H., Bhat, K. P., Eoli, M., Sanson, M., Lasorella, A. & Iavarone, A., Dec 10 2018, In : Nature Medicine.

Research output: Contribution to journalArticle

Neurofibromatosis 1
Glioma
Tumors
Genes
Isocitrate Dehydrogenase
Untranslated RNA
Long Noncoding RNA
Language Development
Comparative Genomic Hybridization
Penetrance
2017

Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis

Schettino, C., Caranci, F., Lus, G., Signoriello, E., Eoli, M., Anghileri, E., Pollo, B., Melone, M. A. B., Di Iorio, G., Finocchiaro, G., Ugga, L. & Tedeschi, E., Oct 1 2017, In : Quantitative Imaging in Medicine and Surgery. 7, 5, p. 592-597 6 p.

Research output: Contribution to journalArticle

Acute Hemorrhagic Leukoencephalitis
Glioblastoma
Glioma
Gait Ataxia
Acute Disseminated Encephalomyelitis

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study

Brandes, A. A., Finocchiaro, G., Zagonel, V., Reni, M., Fabi, A., Caserta, C., Tosoni, A., Eoli, M., Lombardi, G., Clavarezza, M., Paccapelo, A., Bartolini, S., Cirillo, L., Agati, R. & Franceschi, E., 2017, In : Oncotarget. 8, 33, p. 55575-55581 7 p.

Research output: Contribution to journalArticle

Glioblastoma
Survival
Neoplasms
fotemustine
Angiogenesis Inhibitors

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study

Brandes, AA., Finocchiaro, G., Zagonel, V., Reni, M., Fabi, A., Caserta, C., Tosoni, A., Eoli, M., Lombardi, G., Clavarezza, M., Paccapelo, A., Bartolini, S., Cirillo, L., Agati, R. & Franceschi, E., 2017, In : Oncotarget. 8, 33, p. 55575-55581 7 p.

Research output: Contribution to journalArticle

Glioblastoma
Survival
Neoplasms
fotemustine
Angiogenesis Inhibitors
2016

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Brandes, A. A., Finocchiaro, G., Zagonel, V., Reni, M., Caserta, C., Fabi, A., Clavarezza, M., Maiello, E., Eoli, M., Lombardi, G., Monteforte, M., Proietti, E., Agati, R., Eusebi, V. & Franceschi, E., Sep 1 2016, In : Neuro-Oncology. 18, 9, p. 1304-1312 9 p.

Research output: Contribution to journalArticle

fotemustine
Glioblastoma
Confidence Intervals
Survival Rate
Survival

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Brandes, A., Finocchiaro, G., Zagonel, V., Reni, M., Caserta, C., Fabi, A., Clavarezza, M., Maiello, E., Eoli, M., Lombardi, G., Monteforte, M., Proietti, E., Agati, R., Eusebi, V. & Franceschi, E., Sep 1 2016, In : Neuro-Oncology. 18, 9, p. 1304-1312 9 p.

Research output: Contribution to journalArticle

fotemustine
Glioblastoma
Confidence Intervals
Survival Rate
Survival

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Brandes, A., Finocchiaro, G., Zagonel, V., Reni, M., Caserta, C., Fabi, A., Clavarezza, M., Maiello, E., Eoli, M., Lombardi, G., Monteforte, M., Proietti, E., Agati, R., Eusebi, V. & Franceschi, E., Sep 1 2016, In : Neuro-Oncology. 18, 9, p. 1304-1312 9 p.

Research output: Contribution to journalArticle

fotemustine
Glioblastoma
Confidence Intervals
Survival Rate
Survival

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Brandes, A., Finocchiaro, G., Zagonel, V., Reni, M., Caserta, C., Fabi, A., Clavarezza, M., Maiello, E., Eoli, M., Lombardi, G., Monteforte, M., Proietti, E., Agati, R., Eusebi, V. & Franceschi, E., Sep 1 2016, In : Neuro-Oncology. 18, 9, p. 1304-1312 9 p.

Research output: Contribution to journalArticle

fotemustine
Glioblastoma
Confidence Intervals
Survival Rate
Survival

Clonal evolution of glioblastoma under therapy

Wang, J., Cazzato, E., Ladewig, E., Frattini, V., Rosenbloom, D. I. S., Zairis, S., Abate, F., Liu, Z., Elliott, O., Shin, Y. J., Lee, J. K., Lee, I. H., Park, W. Y., Eoli, M., Blumberg, A. J., Lasorella, A., Nam, D. H., Finocchiaro, G., Iavarone, A. & Rabadan, R., Jul 1 2016, In : Nature Genetics. 48, 7, p. 768-776 9 p.

Research output: Contribution to journalArticle

Clonal Evolution
Glioblastoma
Recurrence
Therapeutics
Protein Binding

Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature

Elena, A., Melina, C., Raffaele, N., Carlo, B., Vittoria, N., Francesco, A., Gaetano, F. & Marica, E., Jan 1 2016, In : Neurosurgical Review. 39, 1, p. 37-46 10 p.

Research output: Contribution to journalArticle

Glioblastoma
Meta-Analysis
Neoplasm Metastasis
Survival
Recurrence

Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: A randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

Mazza, E. A., Brandes, A., Zanon, S., Eoli, M., Lombardi, G., Faedi, M., Franceschi, E. & Reni, M., Jan 1 2016, In : Cancer Chemotherapy and Pharmacology. 77, 1, p. 115-120 6 p.

Research output: Contribution to journalArticle

Hydroxyurea
Meningioma
Surgery
Toxicity
Therapeutics

Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: A randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

Mazza, E. A., Brandes, A., Zanon, S., Eoli, M., Lombardi, G., Faedi, M., Franceschi, E. & Reni, M., Jan 1 2016, In : Cancer Chemotherapy and Pharmacology. 77, 1, p. 115-120 6 p.

Research output: Contribution to journalArticle

Hydroxyurea
Meningioma
Surgery
Toxicity
Therapeutics
Hydroxyurea
Meningioma
Surgery
Toxicity
Therapeutics
2015
Glioma
Survival
Perfusion Imaging
ROC Curve
Edema

Detection, characterization, and inhibition of FGFR-TACC fusions in IDH wild-type glioma

Di Stefano, A. L., Fucci, A., Frattini, V., Labussiere, M., Mokhtari, K., Zoppoli, P., Marie, Y., Bruno, A., Boisselier, B., Giry, M., Savatovsky, J., Touat, M., Belaid, H., Kamoun, A., Idbaih, A., Houillier, C., Luo, F. R., Soria, J. C., Tabernero, J., Eoli, M. & 8 others, Paterra, R., Yip, S., Petrecca, K., Chan, J. A., Finocchiaro, G., Lasorella, A., Sanson, M. & Iavarone, A., Jul 15 2015, In : Clinical Cancer Research. 21, 14, p. 3307-3317 11 p.

Research output: Contribution to journalArticle

Fibroblast Growth Factor Receptors
Glioma
Glioblastoma
Mutation
Research Design

Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology)

Lombardi, G., Pace, A., Pasqualetti, F., Rizzato, S., Faedi, M., Anghileri, E., Nicolotto, E., Bazzoli, E., Bellu, L., Villani, V., Fabi, A., Ferrazza, P., Gurrieri, L., Dall’Agata, M., Eoli, M., Della Puppa, A., Pambuku, A., D’Avella, D., Berti, F., Rudà, R. & 1 others, Zagonel, V., Nov 1 2015, In : Journal of Neuro-Oncology. 125, 2, p. 359-367 9 p.

Research output: Contribution to journalArticle

temozolomide
Glioblastoma
Multicenter Studies
Retrospective Studies
Survival

VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab

Di Stefano, A. L., Labussiere, M., Lombardi, G., Eoli, M., Bianchessi, D., Pasqualetti, F., Farina, P., Cuzzubbo, S., Gallego-Perez-Larraya, J., Boisselier, B., Ducray, F., Cheneau, C., Moglia, A., Finocchiaro, G., Marie, Y., Rahimian, A., Hoang-Xuan, K., Delattre, J. Y., Mokhtari, K. & Sanson, M., 2015, In : Journal of Neuro-Oncology. 121, 3, p. 499-504 6 p.

Research output: Contribution to journalArticle

Glioblastoma
Single Nucleotide Polymorphism
Blood Vessels
temozolomide
Genotype
2014

A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients

Mancuso, P., Calleri, A., Gregato, G., Labanca, V., Quarna, J., Antoniotti, P., Cuppini, L., Finocchiaro, G., Eoli, M., Rosti, V. & Bertolini, F., Dec 15 2014, In : PLoS One. 9, 12, e114713.

Research output: Contribution to journalArticle

Endothelial cells
endothelial cells
Blood
Endothelial Cells
neoplasms

Fluorescein-guided surgery for malignant gliomas: A review

Acerbi, F., Cavallo, C., Broggi, M., Cordella, R., Anghileri, E., Eoli, M., Schiariti, M., Broggi, G. & Ferroli, P., Oct 1 2014, In : Neurosurgical Review. 37, 4, p. 547-557 11 p.

Research output: Contribution to journalArticle

Fluorescein
Glioma
Confocal Microscopy
Neurosurgery
Glioblastoma

Is fluorescein-guided technique able to help in resection of high-grade gliomas?

Acerbi, F., Broggi, M., Eoli, M., Anghileri, E., Cavallo, C., Boffano, C., Cordella, R., Cuppini, L., Pollo, B., Schiariti, M., Visintini, S., Orsi, C., La Corte, E., Broggi, G. & Ferroli, P., 2014, In : Neurosurgical Focus. 36, 2, E5.

Research output: Contribution to journalArticle

Fluorescein
Glioma
Coloring Agents
Neoplasms
Tumor Burden

Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48

Pensato, V., Castellotti, B., Gellera, C., Pareyson, D., Ciano, C., Nanetti, L., Salsano, E., Piscosquito, G., Sarto, E., Eoli, M., Moroni, I., Soliveri, P., Lamperti, E., Chiapparini, L., Di Bella, D., Taroni, F. & Mariotti, C., 2014, In : Brain. 137, 7, p. 1907-1920 14 p.

Research output: Contribution to journalArticle

Paraplegia
Phenotype
Corpus Callosum
Genes
Mutation

Parametric response maps of perfusion MRI may identify recurrent glioblastomas responsive to bevacizumab and irinotecan

Aquino, D., Di Stefano, A. L., Scotti, A., Cuppini, L., Anghileri, E., Finocchiaro, G., Bruzzone, M. G. & Eoli, M., Mar 27 2014, In : PLoS One. 9, 3, e90535.

Research output: Contribution to journalArticle

irinotecan
blood volume
Glioblastoma
Magnetic resonance imaging
Blood
2013
Fluorescein
Glioma
Neoplasms
Ethics Committees
Tumor Burden

Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres

Patanè, M., Porrati, P., Bottega, E., Morosini, S., Cantini, G., Girgenti, V., Rizzo, A., Eoli, M., Pollo, B., Sciacca, F. L., Pellegatta, S. & Finocchiaro, G., Dec 11 2013, In : Molecular Cancer. 12, 1, 160.

Research output: Contribution to journalArticle

NF-kappa B
Gene Deletion
Glioblastoma
Epidermal Growth Factor Receptor
Epidermal Growth Factor
irinotecan
Endothelial cells
Glioblastoma
endothelial cells
Endothelial Cells

The somatic genomic landscape of glioblastoma

Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., Beroukhim, R., Bernard, B., Wu, C. J., Genovese, G., Shmulevich, I., Barnholtz-Sloan, J., Zou, L., Vegesna, R., Shukla, S. A., Ciriello, G. & 31 others, Yung, W. K., Zhang, W., Sougnez, C., Mikkelsen, T., Aldape, K., Bigner, D. D., Van Meir, E. G., Prados, M., Sloan, A., Black, K. L., Eschbacher, J., Finocchiaro, G., Friedman, W., Andrews, D. W., Guha, A., Iacocca, M., O'Neill, B. P., Foltz, G., Myers, J., Weisenberger, D. J., Penny, R., Kucherlapati, R., Perou, C. M., Hayes, D. N., Cuppini, L., DiMeco, F., Eoli, M., Maderna, E., Pollo, B., Saini, M. & TCGA Research Network, Oct 10 2013, In : Cell. 155, 2

Research output: Contribution to journalArticle

Glioblastoma
Tumors
Telomerase
Biomarkers
Neoplasms
2012

Central nervous system lymphoma occurring in a patient with neurofibromatosis type 1 (von Recklinghausen disease)

Eoli, M., Bianchessi, D., Di Stefano, A. L., Prodi, E., Anghileri, E. & Finocchiaro, G., Mar 23 2012, In : Neurological Sciences. 33, 6, p. 1429-1433 5 p.

Research output: Contribution to journalArticle

Neurofibromatosis 1
Lymphoma
Central Nervous System
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Brain Neoplasms

FABP4 is a candidate marker of cerebellar liponeurocytomas

Anghileri, E., Eoli, M., Paterra, R., Ferroli, P., Pollo, B., Cuccarini, V., Maderna, E., Tringali, G., Saini, M., Salsano, E. & Finocchiaro, G., Jul 2012, In : Journal of Neuro-Oncology. 108, 3, p. 513-519 7 p.

Research output: Contribution to journalArticle

Fatty Acid-Binding Proteins
Medulloblastoma
Central Nervous System Neoplasms
Adipocytes
Cerebellum

NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma

Speranza, M. C., Frattini, V., Pisati, F., Kapetis, D., Porrati, P., Eoli, M., Pellegatta, S. & Finocchiaro, G., Jul 2012, In : Oncotarget. 3, 7, p. 723-734 12 p.

Research output: Contribution to journalArticle

Glioblastoma
Glioma
Neoplasms
Disease-Free Survival
Brain
2011

DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence

Menghi, F., Orzan, F. N., Eoli, M., Farinotti, M., Maderna, E., Pisati, F., Bianchessi, D., Valletta, L., Lodrini, S., Galli, G., Anghileri, E., Pellegatta, S., Pollo, B. & Gaetano, F., 2011, In : The oncologist. 16, 10, p. 1440-1450 11 p.

Research output: Contribution to journalArticle

Leptin Receptors
Cyclin-Dependent Kinases
Meningioma
Microarray Analysis
Oligonucleotide Array Sequence Analysis
2009

Cisplatinum and BCNU chemotherapy in primary glioblastoma patients

Silvani, A., Gaviani, P., Lamperti, E. A., Eoli, M., Falcone, C., DiMeco, F., Milanesi, I. M., Erbetta, A., Boiardi, A., Fariselli, L. & Salmaggi, A., 2009, In : Journal of Neuro-Oncology. 94, 1, p. 57-62 6 p.

Research output: Contribution to journalArticle

Carmustine
Glioblastoma
Drug Therapy
Disease-Free Survival
Radiotherapy

Genetic signature of adult gliomas and correlation with MRI features

Bruzzone, M. G., Eoli, M., Cuccarini, V., Grisoli, M., Valletta, L. & Finocchiaro, G., Oct 2009, In : Expert Review of Molecular Diagnostics. 9, 7, p. 709-720 12 p.

Research output: Contribution to journalArticle

Glioblastoma
Glioma
Clinical Trials
Therapeutics

High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray

Yin, D., Ogawa, S., Kawamata, N., Tunici, P., Finocchiaro, G., Eoli, M., Ruckert, C., Huynh, T., Liu, G., Kato, M., Sanada, M., Jauch, A., Dugas, M., Black, K. L. & Koeffler, H. P., May 2009, In : Molecular Cancer Research. 7, 5, p. 665-677 13 p.

Research output: Contribution to journalArticle

Glioblastoma
Oligonucleotide Array Sequence Analysis
Single Nucleotide Polymorphism
Uniparental Disomy
p53 Genes

Systemic sagopilone (ZK-EPO) treatment of patients with recurrent malignant gliomas

Silvani, A., Gaviani, P., Fiumani, A., Scaioli, V., Lamperti, E., Eoli, M., Botturi, A. & Salmaggi, A., 2009, In : Journal of Neuro-Oncology. 95, 1, p. 61-64 4 p.

Research output: Contribution to journalArticle

Glioma
Safety
Therapeutics
Astrocytoma
Glioblastoma